scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VACCINE.2009.02.035 |
P698 | PubMed publication ID | 19428864 |
P50 | author | Daniil Korenkov | Q42115794 |
Larisa Rudenko | Q42115804 | ||
Svetlana Donina | Q90213430 | ||
Galina Petukhova | Q105046068 | ||
P2093 | author name string | Tatiana Chirkova | |
Anatoly Naikhin | |||
P2860 | cites work | Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 |
Human lymphocyte apoptosis after exposure to influenza A virus | Q33842341 | ||
Vaccination strategies for mucosal immune responses | Q33975703 | ||
A time to kill: viral manipulation of the cell death program | Q34134292 | ||
Nasal vaccines | Q34343241 | ||
Influenza virus induction of apoptosis by intrinsic and extrinsic mechanisms | Q35213616 | ||
Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection | Q43654251 | ||
The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation | Q44204966 | ||
IgA, IgA subclasses, and secretory component levels in oral fluid collected from subjects after parental influenza vaccination | Q44356910 | ||
Apoptosis and reduced influenza A virus specific CD8+ T cells in aging mice | Q45732396 | ||
Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection | Q45735758 | ||
Cytokine mRNAs in the nasal-associated lymphoid tissue during influenza virus infection and nasal vaccination | Q45745329 | ||
Destruction of lymphocytes by a virulent avian influenza A virus | Q45843448 | ||
IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration | Q47773345 | ||
Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo. | Q52010404 | ||
Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88 | Q57111471 | ||
The Waldeyer Ring Equivalent in the Rat: a Model for Analysis of Oronasopharyngeal Immune Responses | Q58286674 | ||
Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase | Q71565986 | ||
Isolation and characterization of mouse nasal-associated lymphoid tissue | Q73233436 | ||
Nasal immune system: distinctive Th0 and Th1/Th2 type environments in murine nasal-associated lymphoid tissues and nasal passage, respectively | Q77530752 | ||
Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa | Q77838475 | ||
P433 | issue | 19 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
influenza vaccine | Q383260 | ||
attenuated vaccine | Q1810913 | ||
P304 | page(s) | 2580-2587 | |
P577 | publication date | 2009-02-20 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Comparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine (LAIV) utilizing a mouse nasal-associated lymphoid tissue (NALT) separation method | |
P478 | volume | 27 |
Q39451665 | Alveolar macrophages contribute to respiratory tolerance by inducing FoxP3 expression in naive T cells |
Q30382809 | Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine. |
Q30365079 | Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus. |
Q30399923 | Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets |
Q30394240 | Human monoclonal antibodies broadly neutralizing against influenza B virus |
Q98189278 | Immunogenicity and efficacy comparison of MDCK cell-based and egg-based live attenuated influenza vaccines of H5 and H7 subtypes in ferrets |
Q30226518 | Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries. |
Q38028996 | Mucosal immunity and nasal influenza vaccination |
Q35066281 | Nasal immunity to staphylococcal toxic shock is controlled by the nasopharynx-associated lymphoid tissue |
Q30205252 | Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus |
Q30148631 | Tackling a novel lethal virus: a focus on H7N9 vaccine development. |
Q35103033 | The development and function of mucosal lymphoid tissues: a balancing act with micro-organisms |